Literature DB >> 2372054

Activation of insulin-like growth factor gene expression during work-induced skeletal muscle growth.

D L DeVol1, P Rotwein, J L Sadow, J Novakofski, P J Bechtel.   

Abstract

We have investigated the hypothesis that there is local regulation of insulin-like growth factor (IGF) gene expression during skeletal muscle growth. Compensatory hypertrophy was induced in the soleus, a predominantly slow-twitch muscle, and plantaris, a fast-twitch muscle, in 11- to 12-wk-old female Wistar rats by unilateral cutting of the distal gastrocnemius tendon. Animals were killed 2, 4, or 8 days later, and muscles of the nonoperated leg served as controls. Muscle weight increased throughout the experimental period, reaching 127% (soleus) or 122% (plantaris) of control values by day 8. In both growing muscles, IGF-I mRNA, quantitated by a solution-hybridization nuclease-protection assay, rose by nearly threefold on day 2 and remained elevated throughout the experimental period. IGF-II mRNA levels also increased over controls. A more dramatic response was seen in hypophysectomized rats, where IGF-I mRNA levels rose by 8- to 13-fold, IGF-II values by 3- to 7-fold, and muscle mass increased on day 8 to 149% (soleus) or 133% (plantaris) of the control contralateral limb. These results indicate that signals propagated during muscle hypertrophy enhance the expression of both IGF genes, that modulation of IGF-I mRNA levels can occur in the absence of growth hormone, and that locally produced IGF-I and IGF-II may play a role in skeletal muscle growth.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2372054     DOI: 10.1152/ajpendo.1990.259.1.E89

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  66 in total

1.  Regulation of mouse skeletal muscle L-type Ca2+ channel by activation of the insulin-like growth factor-1 receptor.

Authors:  O Delbono; M Renganathan; M L Messi
Journal:  J Neurosci       Date:  1997-09-15       Impact factor: 6.167

2.  A personal history of veterinary public health.

Authors:  J H Steele
Journal:  Vet Herit       Date:  1996-12

3.  Muscle IGF-I Ea, MGF, and myostatin mRNA expressions after compensatory overload in hypophysectomized rats.

Authors:  Akihiko Yamaguchi; Takahiko Fujikawa; Seita Shimada; Isao Kanbayashi; Masaru Tateoka; Hideaki Soya; Hidekatsu Takeda; Isao Morita; Kunio Matsubara; Toshihiro Hirai
Journal:  Pflugers Arch       Date:  2006-08-29       Impact factor: 3.657

Review 4.  New fundamental resistance exercise determinants of molecular and cellular muscle adaptations.

Authors:  Marco Toigo; Urs Boutellier
Journal:  Eur J Appl Physiol       Date:  2006-08       Impact factor: 3.078

5.  Lin-28 binds IGF-2 mRNA and participates in skeletal myogenesis by increasing translation efficiency.

Authors:  Anna Polesskaya; Sylvain Cuvellier; Irina Naguibneva; Arnaud Duquet; Eric G Moss; Annick Harel-Bellan
Journal:  Genes Dev       Date:  2007-05-01       Impact factor: 11.361

Review 6.  Cellular mechanisms regulating protein synthesis and skeletal muscle hypertrophy in animals.

Authors:  Mitsunori Miyazaki; Karyn A Esser
Journal:  J Appl Physiol (1985)       Date:  2008-11-26

Review 7.  Excitation-transcription coupling in skeletal muscle: the molecular pathways of exercise.

Authors:  Kristian Gundersen
Journal:  Biol Rev Camb Philos Soc       Date:  2010-10-06

Review 8.  Cytokines in exertion-induced skeletal muscle injury.

Authors:  J G Cannon; B A St Pierre
Journal:  Mol Cell Biochem       Date:  1998-02       Impact factor: 3.396

9.  Conditional activation of akt in adult skeletal muscle induces rapid hypertrophy.

Authors:  Ka-Man V Lai; Michael Gonzalez; William T Poueymirou; William O Kline; Erqian Na; Elizabeth Zlotchenko; Trevor N Stitt; Aris N Economides; George D Yancopoulos; David J Glass
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

10.  Endotoxin-induced growth hormone resistance in skeletal muscle.

Authors:  Yu Chen; Sumita Sood; Vidya M R Krishnamurthy; Peter Rotwein; Ralph Rabkin
Journal:  Endocrinology       Date:  2009-05-14       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.